Sample interview questions: How do you assess and manage potential complications related to patients with implanted total artificial lungs (TALs)?
Sample answer:
When assessing and managing potential complications related to patients with implanted total artificial lungs (TALs), as a cardiac nurse, it is crucial to possess a comprehensive understanding of the device, its functioning, and the potential complications that may arise. Here are some key steps and considerations for assessing and managing complications in patients with TALs:
-
Regular Monitoring: Regular and meticulous monitoring of the patient’s vital signs, including blood pressure, heart rate, respiratory rate, and oxygen saturation levels, is essential. Continuous monitoring of the TAL device’s functioning, such as pump speed, pressure, and alarms, is also crucial for early detection of any complications.
-
Assessing Device Function: Regularly assess the TAL device for proper functioning, including checking for any mechanical issues, fluid leaks, or signs of infection around the device site. Ensure that the device is well-positioned and secure, and assess the integrity of any connecting tubes or cannulas.
-
Monitoring Oxygenation and Ventilation: Assess the patient’s oxygenation and ventilation status by closely monitoring arterial blood gases, pulse oximetry, and end-tidal carbon dioxide levels. Any significant changes or abnormalities should be promptly addressed and reported to the healthcare team.
-
Infection Control: Implement strict infection control measures to prevent device-related infections. Follow proper hand hygiene protocols and ensure sterile techniques during any procedures involving the TAL device. Monitor for signs of infection, such as redness, swelling, warmth, or discharge at the device site.
-
Anticoagulation Management: Patients with TALs usually require anticoagulation therapy to prevent blood clot formation within the device. Monitor the patient’s coagulation parameters, such as prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT), to ensure therapeutic anticoagulation levels and minimize the risk of bleeding or clotting complications.
-
Medication Management: Review the patient’s … Read full answer
Source: https://hireabo.com/job/2_0_15/Cardiac%20Nurse